inceptive.lifeHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $120MM
Inceptive is a molecule structure platform that designs biotechnology software. With a mission to create more accessible medicine, Inceptive scale experiments with RNA molecules to create the next generation of biological software. The company also uses machine learning to develop complex molecule functionality and design techniques. Inceptive was founded by Jakob Uszkoreit and Rhiju Das in 2021 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/20/2023 | Series A | $100MM | $xx.xx | $476.75MM | Andreessen Horowitz, Nvidia, Obvious Venture, Section 32 | |
Price per Share
$xx.xx
Shares Outstanding
7,023,012
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Andreessen Horowitz, Nvidia, Obvious Venture, Section 32
|
||||||
01/01/2022 | Series Seed-2 | $6.45MM | $xx.xx | $108.06MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,800,466
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/01/2022 | Series Seed-1 | $13.55MM | $xx.xx | $108.06MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,025,901
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|